Judy Blumstock

CEO | Diamond Therapeutics

Ms. Blumstock has over 25 years of venture capital and private equity experience, spanning early to late-stage investments in life sciences and biotechnology. Her experience prior to founding Diamond Therapeutics includes MaRS Innovation (now TIAP), Genesys Capital, RBC Capital Partners Life Science Fund and DRI Capital. Ms. Blumstock has an MBA in finance from Columbia Business School and a BSc from the University of Toronto.